In a move that health experts say may reduce the number of fentanyl deaths, the FDA has approved over-the-counter sales of ...
The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the most ...
After its approval, the first OTC product didn't actually hit store shelves until September 2023. This followed decades of ...
About CannQuit-O CannQuit-O is a chewable tablet with unique characteristics provided by novel combination of registered/FDA-approved polymers allowing for rapid and sustained release of its active ...
Providing access to naloxone and appropriate training can protect workers and possibly save someone's life, says ISEA.
The FDA has even approved for public sale devices that administer fixed doses of naloxone for opioid overdose and epinephrine ...
Narcan is the FDA-approved nasal form of naloxone for the emergency treatment of a known or suspected opioid overdose. The ...
The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the emergency ...
Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone ...
In a move that health experts say may reduce the number of fentanyl deaths, the FDA has approved over-the-counter sales of Narcan nasal spray -- a medication that rapidly reverses fentanyl overdose.